• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by Blue Water Acquisition Corp.

    6/9/25 4:30:04 PM ET
    $BLUW
    Get the next $BLUW alert in real time by email
    8-A12B 1 form8-a12b.htm 8-A12B

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-A

     

    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
    PURSUANT TO SECTION 12(b) OR (g) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

     

     

    Blue Water Acquisition Corp. III

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   33-2301550

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S Employer

    Identification No.)

     

    15 E. Putnam Avenue    
    Suite 363    
    Greenwich, CT   06830
    (Address of principal executive offices)   (Zip Code)

     

    Securities to be registered pursuant to Section 12(b) of the Act:

     

    Title of each class
    to be registered
      Name of each exchange on which
    each class is to be registered
    Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   The Nasdaq Stock Market LLC
    Warrants entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share   The Nasdaq Stock Market LLC

     

    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

     

    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

     

    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

     

    Securities Act registration statement or Regulation A offering statement file number to which this form relates:   333-285075  

     

    Securities to be registered pursuant to Section 12(g) of the Act:

     

    N/A

     

    (Title of class)

     

     

     

    (Title of class)

     

     

     

     

     

     

    INFORMATION REQUIRED IN REGISTRATION STATEMENT

     

    Item 1. Description of Registrant’s Securities to be Registered.

     

    The securities to be registered hereby are (1) units, each consisting of one Class A ordinary share and one-half of one redeemable warrant, (2) Class A ordinary shares, par value $0.0001 per share, and (3) warrants entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share of Blue Water Acquisition Corp. III, a Cayman Islands exempted company (the “Registrant”). The description of the units, Class A ordinary shares and warrants set forth under the heading “Description of Securities” in the Registrant’s prospectus forming a part of its Registration Statement on Form S-1 (File No. 333-285075), originally filed with the Securities and Exchange Commission on February 20, 2025, as thereafter amended and supplemented from time to time (the “Registration Statement”), to which this Form 8-A relates is incorporated by reference herein. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is hereby also incorporated by reference herein.

     

    Item 2. Exhibits.

     

    Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed, because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

     

    2 of 3

     

     

    SIGNATURE

     

    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

     

    (Registrant)  Blue Water Acquisition Corp. III  

     

    Date June 9, 2025  

     

    By: /s/ Joseph Hernandez  
    Name: Joseph Hernandez  
    Title: Chief Executive Officer  

     

    3 of 3

     

    Get the next $BLUW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Blue Water Acquisition Iii Llc bought 430,000 units of Class A ordinary shares (SEC Form 4)

      4 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/12/25 6:14:30 PM ET
      $BLUW
    • Chief Executive Officer Hernandez Joseph bought 430,000 units of Class A ordinary shares (SEC Form 4)

      4 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/12/25 4:27:44 PM ET
      $BLUW

    $BLUW
    Financials

    Live finance-specific insights

    See more
    • Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.

      GREENWICH, Conn., July 30, 2021 /PRNewswire/ --  Blue Water Acquisition Corp. (NASDAQ:BLUW) ("Blue Water"), a special purpose acquisition company ("SPAC") led by Joseph Hernandez, today announced that it has scheduled a special meeting of its stockholders (the "Special Meeting") to, among other things, consider and vote on a proposal to approve the transactions contemplated by the previously announced merger agreement pursuant to which Clarus Therapeutics, Inc. ("Clarus") will merge with a wholly-owned subsidiary of Blue Water (the "Business Combination") and seek to become a publicly listed company. Subject to stockholder approval and satisfaction of customary closing conditions, Clarus and

      7/30/21 9:29:00 AM ET
      $BLUW

    $BLUW
    SEC Filings

    See more
    • Blue Water Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Blue Water Acquisition Corp. III (0002050501) (Filer)

      6/12/25 6:04:42 AM ET
      $BLUW
    • SEC Form 424B4 filed by Blue Water Acquisition Corp.

      424B4 - Blue Water Acquisition Corp. III (0002050501) (Filer)

      6/10/25 7:55:15 PM ET
      $BLUW
    • SEC Form CERT filed by Blue Water Acquisition Corp.

      CERT - Blue Water Acquisition Corp. III (0002050501) (Filer)

      6/10/25 8:55:24 AM ET
      $BLUW

    $BLUW
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $BLUW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $BLUW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies

      Business combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021 Combined company to be renamed Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc.'s common stock and warrants will commence trading on the Nasdaq Global Market on September 10, 2021, under the ticker symbols "CRXT" and "CRXTW," respectively Gross proceeds totaled approximately $25.3 million NORTHBROOK, Ill. and GREENWICH, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women (

      9/9/21 12:46:01 PM ET
      $BLUW
    • Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.

      GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUW), a special purpose acquisition company ("Blue Water"), today announced that its stockholders have voted to approve the proposed business combination (the "Business Combination") with Clarus Therapeutics, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women ("Clarus") at its special meeting of stockholders (the "Special Meeting") held today, August 27, 2021. Holders of approximately 73.95% of Blue Water's issued and outstanding shares cast votes at the Special Meeting. Approximately 69.57% o

      8/27/21 12:58:37 PM ET
      $BLUW
      $BLUWU
      Business Services
      Finance
    • Blue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021

      NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) ("Blue Water" or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned business combination with Clarus Therapeutics, Inc. ("Clarus"), announced today that the special meeting of its stockholders (the "Special Meeting") originally scheduled for Thursday, August 12, 2021, is being postponed to Friday, August 27, 2021. As a result of this change, the Special Meeting will now be held at 10:00 a.m., Eastern Time, on August 27, 2021, exclusively via a live audio webcast at https://www.cstproxy.com/bluewateracquisition/2021. Also as a result of this c

      8/11/21 5:28:45 PM ET
      $BLUW
      $BLUWU
      Business Services
      Finance
    • SEC Form SC 13G filed by Blue Water Acquisition Corp.

      SC 13G - Blue Water Acquisition Corp. (0001817944) (Subject)

      5/10/21 4:05:31 PM ET
      $BLUW
    • SEC Form SC 13G/A filed

      SC 13G/A - Blue Water Acquisition Corp. (0001817944) (Subject)

      2/12/21 11:14:16 AM ET
      $BLUW
    • SEC Form SC 13G filed

      SC 13G - Blue Water Acquisition Corp. (0001817944) (Subject)

      2/12/21 6:34:28 AM ET
      $BLUW
    • Large owner Blue Water Acquisition Iii Llc bought 430,000 units of Class A ordinary shares (SEC Form 4)

      4 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/12/25 6:14:30 PM ET
      $BLUW
    • SEC Form 3 filed by new insider Blue Water Acquisition Iii Llc

      3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/12/25 6:08:06 PM ET
      $BLUW
    • Amendment: SEC Form 3 filed by new insider Hernandez Joseph

      3/A - Blue Water Acquisition Corp. III (0002050501) (Issuer)

      6/12/25 4:32:13 PM ET
      $BLUW